1. Bristol-Myers Squibb Co.
  2. Bristol-Myers Squibb Co. Ownership

Historical shareholding details of Nuveen Asset Management, LLC holdings in Bristol-Myers Squibb Co. (BMY)

Monthly changes of Nuveen Asset Management, LLC shareholding in Bristol-Myers Squibb Co. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Nuveen Asset Management, Llc 1,258,374 0.06%
Jan 31, 2025 Nuveen Asset Management, Llc 1,258,374 0.06%
Dec 31, 2024 Nuveen Asset Management, Llc 10,420,945 0.51%
Dec 31, 2024 Nuveen Asset Management, Llc 1,258,374 0.06%
Nov 30, 2024 Nuveen Asset Management, Llc 1,071,293 0.05%
Oct 31, 2024 Nuveen Asset Management, Llc 1,071,293 0.05%
Sep 30, 2024 Nuveen Asset Management, Llc 8,976,123 0.44%
Sep 30, 2024 Nuveen Asset Management, Llc 1,071,293 0.05%
Aug 31, 2024 Nuveen Asset Management, Llc 3,672 0.00%
Jul 31, 2024 Nuveen Asset Management, Llc 3,672 0.00%
Jun 30, 2024 Nuveen Asset Management, Llc 5,541,941 0.27%
Jun 30, 2024 Nuveen Asset Management, Llc 2,904 0.00%
May 31, 2024 Nuveen Asset Management, Llc 2,904 0.00%
Apr 30, 2024 Nuveen Asset Management, Llc 2,904 0.00%
Mar 31, 2024 Nuveen Asset Management, Llc 9,949,721 0.49%
Mar 31, 2024 Nuveen Asset Management, Llc 2,904 0.00%
Feb 29, 2024 Nuveen Asset Management, Llc 2,904 0.00%
Jan 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Dec 31, 2023 Nuveen Asset Management, Llc 10,705,756 0.53%
Dec 31, 2023 Nuveen Asset Management, Llc 0 0.00%
Nov 30, 2023 Nuveen Asset Management, Llc 0 0.00%
Oct 31, 2023 Nuveen Asset Management, Llc 0 0.00%
Sep 30, 2023 Nuveen Asset Management, Llc 11,350,330 0.56%
Sep 30, 2023 Nuveen Asset Management, Llc 0 0.00%
Aug 31, 2023 Nuveen Asset Management, Llc 0 0.00%
Jul 31, 2023 Nuveen Asset Management, Llc 0 0.00%
Jun 30, 2023 Nuveen Asset Management, Llc 15,003,761 0.72%
Jun 30, 2023 Nuveen Asset Management, Llc 0 0.00%
May 31, 2023 Nuveen Asset Management, Llc 0 0.00%
Mar 31, 2023 Nuveen Asset Management, Llc 16,333,839 0.78%
Dec 31, 2022 Nuveen Asset Management, Llc 17,591,543 0.84%

View all ownership details of Bristol-Myers Squibb Co.